Faruqi & Faruqi, LLP Announces the Investigation of IMS Health Holdings, Inc. (IMS) Over the Proposed Sale of the Company to Quintiles Transnational Holdings, Inc.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of IMS Health Holdings, Inc. (“IMS” or the “Company”) (NYSE:IMS) for potential breaches of fiduciary duties in connection with the sale of the Company to Quintiles Transnational Holdings, Inc. for approximately $8.75 billion.
The Company’s stockholders will only receive 0.3840 Quintiles shares for each share of Company common stock they own, equivalent to $24.94 per share of IMS. However, the offer is below at least one analyst’s price target for IMS stock at $32.00 per share.
If you own common stock in IMS and wish to obtain additional information and protect your investments free of charge, please fill out the form below or contact Juan Monteverde, Esq. either via e-mail at email@example.com or by telephone at (877) 247-4292 or (212) 983-9330.
Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.